{"id": "F2.4-000056-P2", "question": "Report the consequence for VHL c.340+770T>C.", "gold_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100", "gold_rows": [{"variant_name": "VHL c.340+770T>C", "variant_consequence": null}], "generated_rows": [{"gene_symbol": "VHL", "variant_name": "VHL c.340+770T>C"}], "error": null}
{"id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'naevocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000185-S1", "question": "How does the variant RPS6 PHOSPHORYLATION affect response to Everolimus in Adenocarcinoma Of Stomach?", "gold_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RPS6 PHOSPHORYLATION", "gene_symbol": "RPS6", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22343617"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000166-P2", "question": "List genes associated with resistance to Imatinib Mesylate in Acute Myeloid Leukemia.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KIT", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "error": null}
{"id": "F5.2-000015-S1-P1", "question": "Which therapies have variant biomarkers in Squamous Cell Carcinomas Of Head And Neck?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma' AND\n    toLower(rel.disease_name) CONTAINS 'of' AND\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25892145"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Alisertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "HRAS G12V", "gene_symbol": "HRAS", "therapy_name": "Alpelisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30115483"]}, {"variant_name": "PIK3CA E542K", "gene_symbol": "PIK3CA", "therapy_name": "Apitolisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26787751"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Barasertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Celecoxib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577089"]}, {"variant_name": "EGF EXPRESSION", "gene_symbol": "EGF", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25677871"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039", "27207775"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR P546S", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23578570"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "NRAS G13V", "gene_symbol": "NRAS", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28259104"]}, {"variant_name": "SMAD4 Underexpression", "gene_symbol": "SMAD4", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26046389"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "KRAS RS61764370", "gene_symbol": "KRAS", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25081901"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Copanlisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577117"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "MAPK1 E278E", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029"]}, {"variant_name": "MAPK1 E322K", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029", "27004400"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Ibuprofen", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26015511"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "JSI-124", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "ERBB2 Overexpression", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28061634"]}, {"variant_name": "NRG1 Expression", "gene_symbol": "NRG1", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21840482"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Leucovorin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "FGFR2 P253R", "gene_symbol": "FGFR2", "therapy_name": "Pazopanib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23786770"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Platinum Compound", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "NOTCH1 Loss-of-function", "gene_symbol": "NOTCH1", "therapy_name": "Porcupine Inhibitor WNT974", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24277854"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Radiation Therapy", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28476872"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Radiation Therapy", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "Stattic", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Taselisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "HRAS Mutation", "gene_symbol": "HRAS", "therapy_name": "Tipifarnib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["33750196"]}, {"variant_name": "ALDH1A2 Underexpression", "gene_symbol": "ALDH1A2", "therapy_name": "Tretinoin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26634247"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000175", "question": "In Malignant Anus Melanoma, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'anus' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'anal' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "KIT Internal Duplication", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "sensitivity", "disease_name": "Malignant Anus Melanoma", "pmids": ["18421059"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000038-S1-P2", "question": "Which genes influence response to Vemurafenib for Childhood Ganglioglioma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'childhood' AND\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": null, "disease_name": "Ganglioglioma", "pmids": ["26579623", "31985841", "30120137"]}], "generated_rows": [], "error": null}
